Results from a phase 2 study of Relugolix, an oral gonadotropin-releasing hormone receptor antagonist, VS. placebo in women with endometriosis-associated pain.
Results from a phase 2 study of Relugolix, an oral gonadotropin-releasing hormone receptor antagonist, VS. placebo in women with endometriosis-associated pain.
复制标题
Relugolix（一种口服促性腺激素释放激素受体拮抗剂 VS）的 2 期研究结果。
DOI：
--
复制
发表时间：
2017
期刊：
影响因子：
--
通讯作者：
Yutaka Osuga
中科院分区：
文献类型：
--
作者：
Mitsunori Matsuo;Yasushi Hirota;Tomoko Saito-Fujita;Hirofumi Haraguchi;Shota Igaue;Leona Matsumoto;Takehiro Hiraoka;Shun Akaeda;Tomoki Tanaka;Tomoyuki Fujii;Yutaka Osuga;Yutaka Osuga;Yutaka Osuga;Yutaka Osuga;Yutaka Osuga;Yutaka Osuga
